Marrone Bio Relocates Corporate Headquarters to Raleigh, North Carolina
Marrone Bio Innovations (NASDAQ: MBII) has moved its corporate headquarters from Davis, California, to Raleigh, North Carolina, to strengthen its international presence, particularly in European and Latin American markets. The relocation aims to enhance proximity to global markets and benefit from the region's agricultural technology expertise. While the move affects corporate executive positions, Davis remains the hub for research and development. Marrone Bio focuses on sustainable agricultural solutions, offering 18 products supported by over 500 patents.
- Relocation enhances proximity to international markets, supporting growth plans.
- Access to established agricultural technology network in Research Triangle.
- Continued R&D operations in Davis, ensuring innovation sustainability.
- None.
Supports Growth Plans in European and Latin American markets
RALEIGH, N.C., Jan. 06, 2022 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII), an international leader in sustainable bioprotection and plant health solutions, today announced it has relocated its corporate headquarters from Davis, California, to Raleigh, North Carolina, to support the company’s growing presence in markets outside the United States. The move predominantly affects corporate executive positions. Davis will continue to be the hub for the company’s research and development operations, along with a number of support functions.
“International expansion is a key element of our long-term growth plans, and this move provides us greater proximity to global markets,” said Chief Executive Officer Kevin Helash. “We’re delighted to be part of the rich agricultural technology community in the Research Triangle area, and look forward to deepening our relationships with partners and customers based in the area. Given the region’s extensive agricultural focus, we also anticipate tapping into a talent pool of individuals who will be attracted to the growth opportunities Marrone Bio has to offer.”
About Marrone Bio Innovations
Marrone Bio Innovations Inc. (NASDAQ: MBII) is a growth-oriented agricultural company leading the movement to environmentally sustainable farming practices through the discovery, development and sale of innovative biological products for crop protection, crop health and crop nutrition. Our portfolio of 18 products helps customers operate more sustainably while increasing their return on investment. The company’s commercial products are sold globally and supported by a robust portfolio of more than 500 issued and pending patents. Our end markets include row crops; fruits and vegetables; trees, nuts and vines; and greenhouse production. Marrone Bio’s research and development program uses proprietary technologies to isolate and screen naturally occurring microorganisms and plant extracts to create new, environmentally sound solutions in agriculture.
Learn more about Marrone Bio Innovations at www.marronebio.com. We also use our investor relations website, https://investors.marronebio.com, as well as our corporate Twitter account, @Marronebio, as means of disclosing material non-public information, and encourage our investors and others to monitor and review the information we make public in these locations. Follow us on social media: Twitter, LinkedIn and Instagram.
Marrone Bio Innovations Contact:
Clyde Montevirgen
Vice President of Business Development & Investor Relations
Telephone: 530-750-2800
info@marronebio.com
FAQ
What is the recent announcement from Marrone Bio Innovations regarding its headquarters?
How will the relocation of Marrone Bio Innovations affect its operations?
Why did Marrone Bio Innovations choose Raleigh, North Carolina for its new headquarters?
What is the focus area of Marrone Bio Innovations?
What markets does Marrone Bio Innovations aim to expand into?
